Cataract, Refractive, Artificial Intelligence
AI Applications in Diagnostic Imaging
Accelerating the path to progress by identifying and addressing existing barriers.
Cheryl Guttman Krader
Published: Friday, March 1, 2024
Advances in diagnostic imaging have transformed clinical practice in ophthalmology by providing quantitative rather than qualitative information. Now, researchers are looking to use artificial intelligence (AI) to improve diagnostic accuracy and consistency of image interpretation. Achieving this goal, however, requires attention to several issues, said Michael F Chiang MD.
One key challenge for developing useful AI-enabled diagnostic systems relates to the fact the algorithm performance improves as the task narrows. In the real world, however, diagnosis involves many parallel tasks, as clinicians need to integrate data from images with their clinical findings and account for the possibility that patients can have multiple comorbid diseases.
“AI systems are improving rapidly but have yet to reach this level of sophistication,” Dr Chiang said.
To be robust and avoid bias, AI-enabled image diagnostic systems must also be trained on large, diverse data sets to ensure their application is generalisable to the diverse populations encountered in practice. However, the data being used in the research world where AI systems are being developed is often homogenous because it is extracted from a population representing a single centre or geographic region.
Recognising the importance of building large, AI-ready data sets to avoid bias, the National Institutes of Health (NIH) has become involved and established a programme known as Bridge2AI that is providing $130 million in funding across four “data generation” groups. A team led by ophthalmologists at the University of Washington in Seattle is one of the recipients of the funds from this NIH-sponsored project, Dr Chiang said.
Data sharing and collaboration for knowledge discovery are also critical for developing AI-enabled diagnostic systems, and this depends on having imaging devices that adopt imaging standards.
“The problem, however, is that in many existing ocular imaging devices, the data are often locked in proprietary formats and therefore cannot be easily exchanged or retrieved,” Dr Chiang said. He provided some personal examples from his career in academia of how this issue impeded clinical productivity and research.
Addressing the need for conformance to DICOM standards, representatives from three US agencies—the Food and Drug Administration, Office of the National Coordinator for Health Information Technology, and the National Eye Institute—held a workshop in May 2022 focused on improving interoperability among ocular imaging modalities and devices. The meeting led to the identification of knowledge gaps, barriers to progress, and potential approaches for overcoming obstacles.
“Levers that can be pulled to advance the field are described in a published position statement.1 In a nutshell, I am not enthusiastic about funding future studies using ocular imaging devices which do not conform to the DICOM standard because they would not represent the best research or clinical care.”
Noting the need for all stakeholders to work together, Dr Chiang said he was heartened by seeing the community of ocular imaging device vendors appears to be working towards platforms that conform to DICOM standards. Still, he encouraged users of ocular imaging devices to insist on adherence to standards through their interactions with vendors in the device industry.
Dr Chiang spoke at AAO 2023 in San Francisco, US.
1. Goetz KE, Reed AA, Chiang MF, et al. “Accelerating Care: A Roadmap to Interoperable Ophthalmic Imaging Standards in the United States,” Ophthalmology. 2023 Nov 6:S0161-6420(23)00713- 3. doi: 10.1016/j.ophtha.2023.10.001. Epub ahead of print.
Michael F Chiang MD is director of the National Eye Institute, National Institutes of Health, Bethesda, Maryland, US. michael.chiang@nih.gov
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.